Detalhe da pesquisa
1.
Consent document translation expense hinders inclusive clinical trial enrolment.
Nature
; 620(7975): 855-862, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37532930
2.
Spatial mapping of mitochondrial networks and bioenergetics in lung cancer.
Nature
; 615(7953): 712-719, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36922590
3.
Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablation of Non-Small Cell Lung Cancer and Metastatic Disease to the Lungs.
J Vasc Interv Radiol
; 32(8): 1242.e1-1242.e10, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34000388
4.
Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs: Endorsed by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Oncology.
J Vasc Interv Radiol
; 32(8): 1241.e1-1241.e12, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34332724
5.
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
Lancet Oncol
; 18(7): 895-903, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28551359
6.
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study.
Cancer
; 123(8): 1464-1474, 2017 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27925665
7.
Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.
Cancer
; 123(24): 4800-4807, 2017 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29125624
8.
Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy.
J Natl Compr Canc Netw
; 18(9): 1287-1290, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32886906
9.
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan.
Cancer Treat Rev
; 125: 102720, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38502995
10.
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study.
J Clin Oncol
; : JCO2301909, 2024 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38652877
11.
Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib.
JTO Clin Res Rep
; 4(3): 100468, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36923158
12.
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.
J Immunother Cancer
; 11(8)2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37536938
13.
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01.
J Clin Oncol
; 41(29): 4678-4687, 2023 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37327461
14.
CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.
J Immunother Cancer
; 11(9)2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37730274
15.
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer.
Clin Cancer Res
; 28(23): 5136-5148, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36166003
16.
Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC.
JTO Clin Res Rep
; 2(11): 100242, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34806054
17.
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC.
Lung Cancer
; 161: 34-41, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34507111
18.
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44.
Nat Cancer
; 1(12): 1167-1175, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35121931
19.
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 25(16): 5061-5068, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31113840
20.
Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection.
J Thorac Oncol
; 18(9): 1129-1133, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37599046